Hidaka H, Asano T
Biochim Biophys Acta. 1976 Apr 8;429(2):485-97. doi: 10.1016/0005-2744(76)90296-5.
Human blood platelet contained at least three kinetically distinct forms of 3': 5'-cyclic nucleotide phosphodiesterase (3': 5'-cyclic-AMP 5'-nucleotidohydrolase, EC 3.1.4.17) (F I, F II, and F III) which were clearly separated by DEAE-cellulose column chromatography. Although a few properties of the platelet phosphodiesterases such as their substrate affinities and DEAE-cellulose profile resembled somewhat those of the three 3': 5'-cyclic nucleotide phosphodiesterase in rat liver reported by Russell et al. [10], there were pronounced differences in some properties between the platelet and the liver enzymes: (1) the platelet enzymes hydrolyzed both cyclic nucleotides and lacked a highly specific cyclic guanosine 3': 5'-monophosphate (cyclic GMP) phosphodiesterase and (2) kinetic data of the platelet enzymes indicated that cyclic adenosine 3': 5'-monophosphate (cyclic AMP) and cyclic GMP interact with a single catalytic site on the enzyme. F I was a cyclic nucleotide phosphodiesterase with a high Km for cyclic AMP and a negatively cooperative low Km for cyclic GMP. F II hydrolyzed cyclic AMP and cyclic GMP about equally with a high Km for both substrates. F III was low Km phosphodiesterase which hydrolyzed cyclic AMP faster than cyclic GMP. Each cyclic nucleotide acted as a competitive inhibitor of the hydrolysis of the other nucleotide by these three fractions with Ki values similar to the Km values for each nucleotide suggesting that the hydrolysis of both cyclic AMP and cyclic GMP was catalyzed by a single catalytic site on the enzyme. However, cyclic GMP at low concentration (below 10 muM) was an activator of cyclic AMP hydrolysis by F I. Papaverine and EG 626 acted as competitive inhibitors of each fraction with virtually the same Ki value in both assays using either cyclic AMP or cyclic GMP as the substrate. The ratio of cyclic AMP hydrolysis to cyclic GMP hydrolysis by each fraction did not vary significantly after freezing/thawing or heat treatment. These facts also suggest that both nucleotides were hydrolyzed by the same catalytic site on the enzyme. The differences in apparent Ki values for inhibitors such as cyclic nucleotides, papaverine and EG 626 would indicate that three enzymes were different from each other. Centrifugation in a continuous sucrose gradient revealed sedimentation coefficients F I and II had 8.9 S and F III 4.6 S. The molecular weight of these forms, determined by gel filtration on a Sepharose 6B column, were approx. 240 000 (F I and II) and 180 000 (F III). F III was purified extensively (70-fold) from homogenate, with a recovery of approximately 7%.
人血小板中含有至少三种动力学性质不同的3':5'-环核苷酸磷酸二酯酶(3':5'-环磷酸腺苷5'-核苷酸水解酶,EC 3.1.4.17)(F I、F II和F III),通过DEAE - 纤维素柱层析可将它们清晰分离。尽管血小板磷酸二酯酶的一些性质,如它们对底物的亲和力和DEAE - 纤维素图谱,在某种程度上与Russell等人[10]报道的大鼠肝脏中的三种3':5'-环核苷酸磷酸二酯酶相似,但血小板酶和肝脏酶在某些性质上存在明显差异:(1)血小板酶可水解两种环核苷酸,缺乏高度特异性的环鸟苷3':5'-单磷酸(环GMP)磷酸二酯酶;(2)血小板酶的动力学数据表明,环腺苷3':5'-单磷酸(环AMP)和环GMP与酶上的单个催化位点相互作用。F I是一种对环AMP具有高Km值且对环GMP具有负协同低Km值的环核苷酸磷酸二酯酶。F II对环AMP和环GMP的水解能力大致相同,对两种底物均具有高Km值。F III是一种低Km磷酸二酯酶,其水解环AMP的速度比环GMP快。这三种组分中,每种环核苷酸都作为另一种核苷酸水解的竞争性抑制剂,其Ki值与每种核苷酸的Km值相似,这表明环AMP和环GMP的水解都是由酶上的单个催化位点催化的。然而,低浓度(低于10μM)的环GMP是F I催化环AMP水解的激活剂。罂粟碱和EG 626在以环AMP或环GMP为底物的两种测定中,均作为各组分的竞争性抑制剂,其Ki值几乎相同。在冷冻/解冻或热处理后,各组分中环AMP水解与环GMP水解的比率没有显著变化。这些事实也表明两种核苷酸是由酶上的同一催化位点水解的。环核苷酸、罂粟碱和EG 626等抑制剂的表观Ki值差异表明这三种酶彼此不同。在连续蔗糖梯度中离心显示,沉降系数F I和II为8.9 S,F III为4.6 S。通过在Sepharose 6B柱上进行凝胶过滤测定,这些形式的分子量约为240 000(F I和II)和180 000(F III)。F III从匀浆中得到了广泛纯化(70倍),回收率约为7%。